(Q37258815)

19 August 2017

1 reference

title

Hypertension and hepatic steatosis (English)

1 reference

19 August 2017

main subject

arterial hypertension

0 references

author name string

Matthew J Brookes

series ordinal

1

1 reference

19 August 2017

Tariq H Iqbal

series ordinal

2

1 reference

19 August 2017

Brian T Cooper

series ordinal

3

1 reference

19 August 2017

publication date

1 June 2008

1 reference

Current Hypertension Reports

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

182-187

1 reference

Pathogenesis and management issues for non-alcoholic fatty liver disease

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0035-9

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0035-9

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-008-0035-9

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

12 December 2020

Hypertension and fatty liver: guilty by association?

1 reference

12 December 2020

Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.

1 reference

12 December 2020

Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study

1 reference

12 December 2020

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

12 December 2020

Benefits of lifestyle modification in NAFLD.

1 reference

12 December 2020

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

1 reference

12 December 2020

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

12 December 2020

4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells

1 reference

12 December 2020

The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis.

1 reference

12 December 2020

Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones

1 reference

12 December 2020

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

1 reference

12 December 2020

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

12 December 2020

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

1 reference

12 December 2020

Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease.

1 reference

12 December 2020

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

12 December 2020

Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression

1 reference

12 December 2020

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

1 reference

12 December 2020

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease treated by gastroplasty

1 reference

12 December 2020

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement

1 reference

12 December 2020

Hepatic histology in obese patients undergoing bariatric surgery

1 reference

12 December 2020

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

12 December 2020

Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women

1 reference

12 December 2020

Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity

1 reference

12 December 2020

Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese

1 reference

12 December 2020

A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients

1 reference

12 December 2020

Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat.

1 reference

12 December 2020

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

12 December 2020

Gamma-glutamyltransferase: an effect modifier in the association between age and hypertension in a 4-year follow-up study

1 reference

12 December 2020

Review article: role of oxidative stress in the progression of non-alcoholic steatosis

1 reference

12 December 2020

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

12 December 2020

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

12 December 2020

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

12 December 2020

Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

12 December 2020

Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

12 December 2020

Long term prognosis of fatty liver: risk of chronic liver disease and death.

1 reference

12 December 2020

Non-alcoholic steatohepatitis: from cell biology to clinical practice

1 reference

12 December 2020

Pathology of nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S11906-008-0035-9

Identifiers

DOI

1 reference

19 August 2017

1 reference